Proliferation and apoptosis-related gene expression in experimental acquired immunodeficiency syndrome-related simian lymphoma.

Lymphomas in 10 cynomolgus monkeys infected with a simian immunodeficiency virus (SIVsm) were studied with regard to proliferative activity and apoptosis-related gene expression. All were diffuse large-cell lymphomas, showed mono or oligoclonality and a 9/10 diploid cellular DNA content. Expression of a simian homologue to Epstein-Barr virus (HVMF-1) was shown in nine cases. The lymphomas showed moderate to high proliferative activity by Ki67 immunostaining and DNA flow cytometry, and a low number of apoptotic cells detected by TdT-mediated dUTP nick-end labeling (TUNEL). Immunohistochemistry showed abundant tumor infiltrating TIA-1(+) cytotoxic lymphocytes (CTL) and macrophages. Bcl-2, Mcl-1, and also Bax and Bak, but not p53 were demonstrable in the tumor cells by immunostaining. Our findings suggest a causal relationship between HVMF-1 infection and a low apoptotic index of the lymphomas due to the expression of Bcl-2. The apparent inefficient function of tumor-infiltrating CTL could be due to inactivation of CTL and/or resistance of the lymphoma cells to CTL effects. The tumors showed immunoreactivity for CD18, CD29, and CD49d, but not for CD11a, mimicking the phenotype of human Epstein-Barr virus (EBV)-related lymphomas. In summary, our observations indicate a high similarity between this simian model of acquired immunodeficiency syndrome (AIDS)-related lymphomas (ARL) and human ARL and other immunosuppression-related lymphomas.

[1]  L. Cioé,et al.  Detection of infectious simian immunodeficiency virus in B- and T-cell lymphomas of experimentally infected macaques. , 1998, Blood.

[2]  L. Gordon,et al.  BCL-2 expression correlates with lower proliferative activity in the intermediate- and high-grade non-Hodgkin's lymphomas: an Eastern Cooperative Oncology Group and Southwest Oncology Group cooperative laboratory study. , 1998, Blood.

[3]  E. Cesarman,et al.  Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders. , 1997, The American journal of pathology.

[4]  J C Reed,et al.  Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. , 1997, Blood.

[5]  John Calvin Reed.  Double identity for proteins of the Bcl-2 family , 1997, Nature.

[6]  E. Castaños-Vélez,et al.  Protection against mucosal SIVsm challenge in macaques infected with a chimeric SIV that expresses HIV type 1 envelope. , 1996, AIDS research and human retroviruses.

[7]  P. Brousset,et al.  Immunodetection of apoptosis-regulating proteins in lymphomas from patients with and without human immunodeficiency virus infection. , 1996, The American journal of pathology.

[8]  N. Kedersha,et al.  Characterization of GMP-17, a granule membrane protein that moves to the plasma membrane of natural killer cells following target cell recognition. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[9]  P. Biberfeld,et al.  Demonstration of herpesvirus particles in apoptotic bodies of a brain lymphoma in an SIV‐immunodeficient monkey , 1995, International Journal of Cancer.

[10]  E. Castaños-Vélez,et al.  Extracellular matrix proteins and integrin receptors in reactive and non-reactive lymph nodes. , 1995, Immunology.

[11]  Stefan Imreh,et al.  Inhibition of antigen processing by the internal repeat region of the Epstein–Barr virus nuclear antigen-1 , 1995, Nature.

[12]  E. Castaños-Vélez,et al.  B‐cell lymphomagenesis in SIV‐immunosuppressed cynomolgus monkeys , 1995, International journal of cancer.

[13]  A. Minty,et al.  Interleukin-13 gene expression by malignant and EBV-transformed human B lymphocytes. , 1994, European cytokine network.

[14]  I. Ernberg,et al.  DNA of lymphoma‐associated herpesvirus (HVMF1) in SIV‐infected monkeys (Macaca fascicularis) shows homologies to EBNA‐1, ‐2 and ‐5 genes , 1994, International journal of cancer.

[15]  M. McGrath,et al.  Pathogenesis of AIDS lymphomas. , 1994, AIDS.

[16]  I. Ernberg,et al.  Expression of epstein‐barr‐virus‐related nuclear antigens and B‐cell markers in lymphomas of SIV‐immunosuppressed monkeys , 1993, International journal of cancer.

[17]  C. Meijer,et al.  Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency. , 1993, Human pathology.

[18]  P. Anderson,et al.  Cytotoxic effector cell granules recognized by the monoclonal antibody TIA-1 are present in CD8+ lymphocytes in lymph nodes of human immunodeficiency virus-1-infected patients. , 1993, The American journal of pathology.

[19]  R. Mertelsmann,et al.  Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes. , 1992, Blood.

[20]  B. Tribukait,et al.  An improved Hedley method for preparation of paraffin-embedded tissues for flow cytometric analysis of ploidy and S-phase. , 1991, Cytometry.

[21]  P. Biberfeld,et al.  Malignant lymphomas in cynomolgus monkeys infected with simian immunodeficiency virus. , 1990, The American journal of pathology.

[22]  B. Lange,et al.  Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.